Author:
Ballestero Matheus F. M.,Furlanetti Luciano,Podolsky Guilherme G.,de Oliveira Ricardo S.
Publisher
Springer International Publishing
Reference60 articles.
1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20.
2. Youmans JR, Winn HR. Youmans and Winn neurological surgery, 4-volume set, 7e, 7a edição. Philadelphia, PA: Elsevier; 2016.
3. Brat DJ, Aldape K, Colman H, et al. cIMPACT-NOW update 3: recommended diagnostic criteria for “diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol. 2018;136:805–10.
4. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479–89.
5. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011—PubMed. https://pubmed.ncbi.nlm.nih.gov/25304271/. Accessed 8 Nov 2020.